.png)
On May 28, 2016 the DLC leadership sent a Letter to executives with UnitedHealth Group speaking out against UHG's recent decision to limit patient choice to one brand of insulin pump. The topic has raised issues of patient access and safety due to lack of patient empowerment leading to proven declines in self-management and health outcomes. Please see the attached white paper DLC White Paper - United Healthcare Pump Choice - June 2016. This piece was also published as an editorial in the Journal of Diabetes, Metabolic Disorders & Control JDMDC-03-00069.
